Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

The choice between ICD types still should be based on each individual patient’s risk factors, Kenneth Ellenbogen says.

Boston Scientific has proven itself to be a fierce competitor among three major cardiac device makers, with a track record of meaningful innovation and impressive operational chops. Even a prolonged ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Boston Scientific CFO Dan Brennan is set to retire and will transition out of the role at the end of June ...

Michael Mahoney; Chairman of the Board, President, Chief Executive Officer; Boston Scientific Corp Daniel Brennan; Chief Financial Officer, Executive Vice President; Boston Scientific Corp Kenneth ...

Cheng Xin / Getty Images Shares of Boston Scientific (BSX) rose sharply Wednesday after the firm posted first-quarter results that topped analysts' estimates. The Marlborough, Mass.-based medical ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost of doing business this year, according to the company’s ...

Boston Scientific has a 12-month low of $70.97 and a 12-month high of $107.17. The business’s 50 day moving average is $98.68 and its 200-day moving average is $94.92.

Marlborough-based medical device manufacturer Boston Scientific has announced a long-term member of its C-suite will be stepping down as Dan Brennan, the firm’s executive vice president and ...

MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Boston Scientific Corp. (BSX) on Wednesday reported first-quarter profit of $674 million. The Marlborough, Massachusetts-based company said ...

Boston Scientific Corp (BSX) has reported a strong financial performance for the first quarter of 2025, surpassing both earnings per share (EPS) and revenue forecasts. The medical device company ...